Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4af908f02f8ccea6ea47dd8e77408636 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2740-13043 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2830-00 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-64 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-86 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-64 |
filingDate |
2007-10-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bbd5927e18a9856dcde54ab1f143c278 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_977ca3cf4a8ae88a5d1f565719db1428 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_264ada0a1aa94b96e95be5ff36581f34 |
publicationDate |
2010-12-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
EP-2261360-A1 |
titleOfInvention |
Expression vectors with improved safety |
abstract |
The present invention relates to the use of internal promoters in mammalian expression vectors including plasmid vectors and enhancer-deleted retroviral vectors. The retroviral vectors have improved safety and optimal levels of transgene expression and vector titers. |
priorityDate |
2006-10-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |